Universal Quantum, an ion-trap quantum computing company, has joined the Open Quantum Institute (OQI) to apply quantum computing to global health challenges. The collaboration will commence with a drug discovery project focused on endometriosis, a condition affecting 10% of women globally. This project aims to investigate how quantum simulations can accelerate the discovery of non-hormonal, shelf-stable therapeutics.
Universal Quantum will work with OQI collaborators, including experts in biomedicine, computational chemistry, and women’s health. The focus of this effort is on simulating bio-molecular systems using quantum processors and integrating the resulting insights into drug discovery workflows. The OQI, launched by the Geneva Science and Diplomacy Anticipator (GESDA) in collaboration with the UN’s International Telecommunication Union (ITU), CERN, and other international bodies, serves as a platform to support quantum use cases with public benefit in areas such as healthcare and climate science.
Universal Quantum’s involvement in the OQI aligns with its commitment to both developing scalable, fault-tolerant quantum hardware and ensuring the responsible deployment of such technology. The project specifically aims to address the needs of underserved populations in rural or economically developing regions. Universal Quantum CEO Dr. Sebastian Weidt emphasized the importance of integrating domain knowledge with quantum infrastructure to advance science and benefit society.
You can follow more information here.
July 24, 2025
Leave A Comment